These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 30342071)

  • 1. The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions.
    Dunlop BW; Wong A
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():361-379. PubMed ID: 30342071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.
    de Kloet CS; Vermetten E; Geuze E; Kavelaars A; Heijnen CJ; Westenberg HG
    J Psychiatr Res; 2006 Sep; 40(6):550-67. PubMed ID: 16214171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of hypothalamic-pituitary-adrenal axis functioning in posttraumatic stress disorder.
    Jones T; Moller MD
    J Am Psychiatr Nurses Assoc; 2011; 17(6):393-403. PubMed ID: 22142976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder.
    Yehuda R; Giller EL; Southwick SM; Lowy MT; Mason JW
    Biol Psychiatry; 1991 Nov; 30(10):1031-48. PubMed ID: 1661614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of comorbidity and trauma exposure and its timing in shaping HPA axis patterns in depression.
    Mayer SE; Peckins M; Kuhlman KR; Rajaram N; Lopez-Duran NL; Young EA; Abelson JL
    Psychoneuroendocrinology; 2020 Oct; 120():104776. PubMed ID: 32593866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous glucocorticoids to improve extinction learning for post-traumatic stress disorder patients with hypothalamic-pituitary-adrenal-axis dysregulation: a study protocol description.
    de Nooij L; Wirz L; Heling E; Pais M; Hendriks GJ; Verkes RJ; Roozendaal B; Hermans EJ
    Eur J Psychotraumatol; 2024; 15(1):2364441. PubMed ID: 38973398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain.
    Heim C; Ehlert U; Hanker JP; Hellhammer DH
    Psychosom Med; 1998; 60(3):309-18. PubMed ID: 9625218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenal axis activity in post-traumatic stress disorder and cocaine use disorder.
    Hadad NA; Schwendt M; Knackstedt LA
    Stress; 2020 Nov; 23(6):638-650. PubMed ID: 32835581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between hypothalamic-pituitary-adrenal axis gene polymorphisms and posttraumatic stress disorder symptoms.
    Zhang K; Wang L; Li G; Cao C; Fang R; Liu P; Luo S; Zhang X
    Horm Behav; 2020 Jan; 117():104604. PubMed ID: 31655035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of posttraumatic stress disorder.
    Yehuda R
    J Clin Psychiatry; 2001; 62 Suppl 17():41-6. PubMed ID: 11495096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
    Juruena MF; Bocharova M; Agustini B; Young AH
    J Affect Disord; 2018 Jun; 233():45-67. PubMed ID: 29150144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: a meta-analysis.
    Klaassens ER; Giltay EJ; Cuijpers P; van Veen T; Zitman FG
    Psychoneuroendocrinology; 2012 Mar; 37(3):317-31. PubMed ID: 21802212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenal axis activity and sleep in posttraumatic stress disorder.
    Otte C; Lenoci M; Metzler T; Yehuda R; Marmar CR; Neylan TC
    Neuropsychopharmacology; 2005 Jun; 30(6):1173-80. PubMed ID: 15714228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS; Rao MN; Richards A; O'Donovan A; Gibson CJ; Baum T; Metzler TJ; Neylan TC
    Psychoneuroendocrinology; 2018 Feb; 88():136-143. PubMed ID: 29268182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine response to CRF stimulation in veterans with and without PTSD in consideration of war zone era.
    Golier JA; Caramanica K; Yehuda R
    Psychoneuroendocrinology; 2012 Mar; 37(3):350-7. PubMed ID: 21813244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological factors of post-traumatic stress: neuroendocrine aspects].
    Birmes P; Escande M; Gourdy P; Schmitt L
    Encephale; 2000; 26(6):55-61. PubMed ID: 11217539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids and Hippocampal Structure and Function in PTSD.
    Szeszko PR; Lehrner A; Yehuda R
    Harv Rev Psychiatry; 2018; 26(3):142-157. PubMed ID: 29734228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease.
    Naughton M; Dinan TG; Scott LV
    Handb Clin Neurol; 2014; 124():69-91. PubMed ID: 25248580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
    J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPA- and HPT-axis alterations in chronic posttraumatic stress disorder.
    Olff M; Güzelcan Y; de Vries GJ; Assies J; Gersons BP
    Psychoneuroendocrinology; 2006 Nov; 31(10):1220-30. PubMed ID: 17081699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.